REFERENCES
1. Chapman AR, Lee KK, McAllister DA, et al. Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome. JAMA 2017;318:1913-24.
2. Nestelberger T, Boeddinghaus J, Wussler D, et al. APACE Investigators. Predicting major adverse events in patients with acute myocardial infarction. J Am Coll Cardiol 2019;74:842-54.
3. Conway R, Byrne D, Cournane S, O’Riordan D, Coveney S, Silke B. Troponin status predicts 30-day in-hospital mortality. Vessel Plus 2020;4:25.
4. Pal N, Worrall E, Lim A. Controversies in perioperative troponin elevation in non-cardiac surgery. Vessel Plus 2021;5:20.
5. Devereaux PJ, Biccard BM, Sigamani A, et al. Writing Committee for the VISION Study Investigators. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2017;317:1642-51.
6. Thygesen K, Alpert JS, Jaffe AS, et al. Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). Circulation 2018;138:e618-51.
7. Winchester DE. Implementation of high sensitivity troponin in a veterans health system: lessons learned. Vessel Plus 2021;5:1.
